SUMMARY Alcohol inhibits phospholipase (PL) activity in a number of animal models. We have therefore measured prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), liberated by stimulated peripheral blood mononuclear cells (PBMC) and neutrophils respectively in chronic alcoholics and in control subjects. Peripheral blood mononuclear cells from alcoholics produced less PGE2 (p <0.01) and neutrophils produced less LTB4 (p <0 025). Reduced PGE2 production by PBMC of alcoholics was corrected by the addition of exogenous arachidonic acid (p <0 005) whilst neutrophil LTB4 production remained lower in the alcoholics (p <0.01). Percutaneous liver biopsies were undertaken in the 20 alcoholics having abnormal liver function tests. Prostaglandin E2 biosynthesis was lower in PBMC from patients with alcoholic hepatitis than with alcoholic cirrhosis (p <0 05). Analysis of PBMC fatty acid composition demonstrated that endogenous arachidonate and linoleate contents were not significantly different in alcoholics and controls. Cells from controls and alcoholics were incubated with 0, 50 and 150 mmol/l ethanol for two hours but there was no alteration in PGE2 or LTB4 biosynthesis. In summary, we found reduced eicosanoid production by peripheral leucocytes in alcoholics, supporting the hypothesis that chronic alcohol consumption either inhibits membrane bound phospholipase activity or enhances, alternatively, catabolism of eicosanoids. This phenomenon is more marked in alcoholic patients with hepatitis than in those with cirrhosis alone.
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Acute or chronic alcohol consumption may damage the liver of susceptible individuals. This effect is dose related and may also be dependent upon nutritional status and genetic determinants in individual patients. ' Animal experiments have shown that prostaglandin E2 (PGE2) protects the hepatocyte against Dgalactosamine and carbon tetrachloride induced toxicity. Twenty millilitres of venous blood was drawn into sodium heparin vacutainers (Becton-Dickinson, Rutherford, New Jersey, USA) and 10 ml into vacutainers without anticoagulant for isolation of cell and serum respectively. Leucocyte rich plasma obtained after dextran sedimentation was layered on Hypaque-Ficoll gradients (Pharmacia) and centrifuged at 400 g for 20 minutes before harvesting PBMC from the interface. The neutrophils and residual erythrocytes sedimented to the base of the gradient. Identification and counting of PBMC and neutrophils were performed by fluorescent microscopy using ethidium bromide and acridine orange staining. As lymphocytes do not produce appreciable amounts of PGE2,"' secretion was assumed entirely due to monocytes. Esterase staining was used to determine the percentage of monocytes in the mononuclear cell fraction." Cells were resuspended in Dulbecco's phosphate buffered saline (PBS) containing 1 mmol/l glucose to concentration of I x 10" cells/mI. Using these techniques no neutrophils were found in the PBMC fractions and vice tversa. In addition, freshly isolated cells were in excess of 98% of viabile as assessed using fluorescent microscopy with ethidium bromide and acridine orange staining.
OPSONISATION OF ZYMOSAN
One hundred milligrams zymosan A (Sigma) was suspended in 10 ml PBS, allowed to swell overnight, centrifuged to remove fines and resuspended in 10 ml PBS. One millilitre samples were incubated with 1 ml autologous serum for 30 minutes at 37°C. The samples were centrifuged to sediment the opsonised zymosan and washed with PBS to remove residual serum. The opsonised zymosan was resuspended in 5 ml PBS with a final concentration of 2 mg/ ml.
PROSIAGL ANDIN E, AND IlUKOTRIlN1 B4 SECREIIION Half a millilitre of the mononuclear cell suspenision was incubated with 0(5 ml of opsonised zymosan for 30 minutes at 37°C in the presence and absence of 10 nmol arachidonic acid (AA). This time period was found on preliminary experiments to be the most appropriate for optimal secretion of PGE,. Briefly, secretion of PGE2 was shown to increase with time up to 10 minutes, after which the level of secretion remained constant for up to 45 minutes; 0(5 ml of neutrophil suspension was incubated with ()5 ml 4 gsmol/l calcium ionophone A23 187 (Sigma) for 10 minutes at 37°C in the presence and absence of 10 nmol AA.
After incubation samples were placed on ice. Cells and zymosan were removed by centrifugation at 400 g and 4°C for 25 minutes. Prostaglandin E) was determined by radioimmunoassay using PGE2 antiserum (Sigma) according to the method of Bauminger cl al.`Leukotriene B4 content was assessed using LTB4 antiserum (Wellcome) according to the method of Salmon. ' Antisera were found to have only 3% crossreactivity with arachidonic acid and other eicosanoids. PGE2 estimation were validated using thin layer chromatography and LTB4 using high performance liquid chromatography. Intra and interassay variation was less than 15%.
FATTY ACID ANAL YSIS
Lipids from 500 gi of the cell fractions and from 1 10 gu] of serum were extracted with 2.5 ml chloroform: methanol (2:1). Heptadecanoic acid (C17:0) was used as an internal standard. The lower layer was dried down and transesterified as follows: 0(5 ml boron trifluoride methanol (Sigma, Poole, Dorset, UK) was added and incubated at 75°C for 30 minutes. After incubation the samples were extracted three times with 1 ml petroleum ether (40-60°). the petroleum ether was dried down and resuspended in 20 p.l n-hexane. A two ,i sample was injected for each run using a 1-5 mx4 mm column containing 10% Silar 10 C on 100-120 mesh Chromosorb WHP (Pye Unicam, UK). The running temperature was 150-230°C at 4°/min. Fatty acid identification was confirmed by comparison of retention times with authentic standards (Sigma, U K). [range] lower in PBMC from patients abusing alcohol compared with control subjects, the effect being more marked in cells from patients with biochemical and histological evidence of liver damage (p <0.05) (Fig. 1) . Biosynthesis of LTB4 by neutrophils was significantly depressed in alcoholics compared with control subjects (Fig. 2) . Addition of arachidonic acid (AA) to stimulated PBMC resulted in an enhanced PGE2 production by cells from alcoholics ( Fig. 1) whereas LTB4 secretion by neutrophils remained significantly lower in the alcoholic groups in the presence of added arachidonic acid (Fig. 2) . Percutaneous liver biopsies were performed in the 20 alcoholics with abnormal liver function tests; 10 having alcoholic hepatitis and 10 alcoholic cirrhosis. Prostaglandin E2 biosynthesis was significantly lower in patients with hepatitis and with cirrhosis alone (Table 2) . To Prostaglandin E, and leukotriene B4 synthesis by peripheral leucocytes in alcoholics [91 [9] 19] [91 [9] from controls and alcoholics were incubated with 0, 50 and 150 nmol/l ethanol for two hours. Ethanol in these concentrations had no effect on PGE2 synthesis by PBMC or LTB4 release by neutrophils from either alcoholics or control subjects ( Given the limitation that we used peripheral blood leucocytes in this study, we have shown decreased in vtitro biosynthesis of cytoprotective PGE2 by peripheral monocytes, together with decreased LTB4 production by peripheral neutrophils from patients with alcohol related liver disease. These abnormalities were more marked in those with impaired liver function. PGE2 released by PBMC was lowest in the group with alcoholic hepatitis.
The reduced eicosanoid production was not the result endogenous substrate depletion as we found no difference in the total cellular arachidonate and linoleate content of PBMC from alcoholics and controls. The depression in PGE2 biosynthesis by cells from alcoholics was overcome by the addition of exogenous arachidonic acid to PBMC incubates, indicating both the possibility of defective release of endogenous substrate by phospholipases and that the cyclo-oxygenase system was functional. By contrast, LTB4 production by neutrophils from both controls and alcoholics was further suppressed by the addition of exogenous arachidonic acid. Lipoxygenase may have been inhibited by substrate or by feedback inhibition by 15-hydroxyeicosatetraenoic acids (15-HETEs). 7 Diminished eicosanoid concentrations in the in vitro peripheral leucocyte from chronic alcohol abusers may result from reduced endogenous arachidonate availability caused by decreased phospholipase activity or increased catabolism of the measured products (PGE2 and LTB4).
Ethanol increases calcium binding to mammalian membranes, predominantly to the protein calmodulin.
" "The calcium-calmodulin complex associated with the Ca2+-ATPase system, increasing calcium efflux across the cell membrane.2' The consequent reduction in intracellular ionised calcium concentration would in turn reduce calcium dependent phospholipase A2 and C activation. This is supported by the observation that acute ethanol exposure significantly decreases eicosanoid biosynthesis in the isolated perfused rat lung model.2' By contrast, we did not find any significant change in PBMC, PGE2 or neutrophil LTB4 production when these cells from control subjects and alcoholics were incubated in the presence of up to 150 mmol/l ethanol for two hours. This may be related to the relatively long incubation time chosen for our acute ethanol exposure studies.
Peripheral leucocyte eicosanoid production is reduced in patients who abuse alcohol and is most marked in those with active alcoholic hepatitis. It is likely that this alteration in eicosanoid metabolism is the result of reduced release of the substrate arachidonic acid from membrane phospholipids by phospholipase. As neutrophil infiltration is less marked than macrophage and lymphocyte infiltration in alcoholic hepatitis, the findings of reduced PBMC PGE2 may be more relevant than low LTB4 production by the peripheral neutrophil. Consequently, reduced biosynthesis of cytoprotective PGE2 in the liver may predispose to the inflammation of alcoholic hepatitis and the resultant fibrosis so often found in alcohol related liver disease. 
